Scarica l'app Stockscreener
0.3944
2.28%
0.0088
Dopo l'orario di chiusura:
.39
-0.0044
-1.12%
Precedente Chiudi:
$0.3856
Aprire:
$0.395101
Volume 24 ore:
103.60K
Relative Volume:
0.01
Capitalizzazione di mercato:
$16.48M
Reddito:
$20.27M
Utile/perdita netta:
$-63.80M
Rapporto P/E:
-0.2595
EPS:
-1.52
Flusso di cassa netto:
$-68.35M
1 W Prestazione:
-2.38%
1M Prestazione:
-12.53%
6M Prestazione:
-10.79%
1 anno Prestazione:
-65.40%
Intervallo 1D:
$0.3887
$0.40
Intervallo di 1 settimana:
$0.3763
$0.4348
Portata 52W:
$0.1417
$1.27
Carisma Therapeutics Inc Stock (CARM) Company Profile
Nome
Carisma Therapeutics Inc
Settore
Industria
Telefono
(267) 491-6422
Indirizzo
3675 MARKET STREET, PHILADELPHIA
Confronta CARM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CARM
Carisma Therapeutics Inc
|
0.3944 | 16.11M | 20.27M | -63.80M | -68.35M | -1.52 |
|
VRTX
Vertex Pharmaceuticals Inc
|
476.95 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.39 | 60.56B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.64 | 42.41B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
575.42 | 34.96B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.83 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Carisma Therapeutics Inc Stock (CARM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-12 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-12-10 | Downgrade | BTIG Research | Buy → Neutral |
| 2024-04-11 | Iniziato | BTIG Research | Buy |
| 2023-10-03 | Iniziato | CapitalOne | Overweight |
| 2023-07-06 | Iniziato | Evercore ISI | Outperform |
| 2023-05-31 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-05-24 | Iniziato | H.C. Wainwright | Buy |
| 2023-04-14 | Iniziato | Robert W. Baird | Outperform |
Mostra tutto
Carisma Therapeutics Inc Borsa (CARM) Ultime notizie
Carisma Therapeutics Inc. Stock Analysis and ForecastFree Smart Trading Workshop - jammulinksnews.com
What analysts say about Carisma Therapeutics Inc. stockExtraordinary market timing - jammulinksnews.com
What drives Carisma Therapeutics Inc. stock priceFree Stock Market Real-Time Monitoring - jammulinksnews.com
Is Carisma Therapeutics Inc. a good long term investmentExceptional profit margins - jammulinksnews.com
Carisma Therapeutics Transfers Listing to Nasdaq Capital Market - TipRanks
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NVEE, CARM, HLGN on Behalf of Shareholders - Benzinga
How Carisma Therapeutics Inc. stock performs during market volatility200 Percent Profit Outlook - Newser
What makes Carisma Therapeutics Inc. stock price move sharplyFree Top-Rated Stock Analysis - Newser
Why Carisma Therapeutics Inc. stock attracts strong analyst attentionFree VIP Investment Strategies - Newser
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger: TURN, HLGN, CARM, and GNTY - The Malaysian Reserve
Investor Rights Law Firm Investigates Couchbase, Carisma, Enzo Biochem Merger Deals. - AInvest
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger: CARM, GNTY, TSBX, and SAGE - The Malaysian Reserve
Carisma Therapeutics Inc. (NASDAQ:CARM) Given Average Recommendation of “Hold” by Brokerages - Defense World
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
Deal Watch: Novartis To Develop Cardiovascular Therapies With ProFound - insights.citeline.com
Carisma Therapeutics and OrthoCellix Merge to Advance Regenerative Cell Therapy for Orthopedic Diseases - MSN
After laying off most of its staff, struggling Carisma Therapeutics finds a merger partner - The Business Journals
Carisma Therapeutics, OrthoCellix enter definitive merger agreement - Yahoo Finance
Carisma Therapeutics stock soars after proposed merger with OrthoCellix - Investing.com India
CARISMA Therapeutics Plummets 12%: What Drives a Crash Without News? - AInvest
Carisma Therapeutics' 12% Drop: A Mystery Unveiled Through Order Flow and Peer Dynamics - AInvest
CARISMA Therapeutics Plunges 10.36% Amid Market Volatility - AInvest
Compass Therapeutics, Inc. (NASDAQ:CMPX) Shares Sold by Millennium Management LLC - Defense World
Carisma Therapeutics, Inc. (NASDAQ:CARM) Stock Position Decreased by Millennium Management LLC - Defense World
Millennium Management LLC Takes Position in Marker Therapeutics, Inc. (NASDAQ:MRKR) - Defense World
Carisma Therapeutics Secures Nasdaq Listing Approval - TipRanks
Is the 250% Carisma Therapeutics Stock (CARM) Surge a Sucker’s Rally? - The Globe and Mail
Dow Rises Over 50 Points; US Inflation Rate Increases In May - Benzinga
Carisma Therapeutics Stock (CARM) Retreats 35% After a Massive Rally - TipRanks
US Stocks Mixed; JM Smucker Shares Plunge After Q4 Results - Benzinga
Pre-market Movers: EVGN, WINT, CARM, UNCY... - RTTNews
Why Casey's General Stores Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket - Benzinga
Carisma Therapeutics Inc Azioni (CARM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
4.91%
0.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):